SUBMISSION DEADLINE – FRIDAY, JULY 08, 2016 (5:00 PM).
A common critical gap in commercialization of technologies originating from the academic labs is the funding necessary to develop a robust commercialization relevant data package to reduce the risk of investment in early stage technologies. The Indiana CTSI and Indiana University School of Medicine through the office of the Associate Dean for Entrepreneurship and its Industry Collaboration Portal (ICP), are partnering with the newly created Indiana Center for Biomedical Innovation (ICBI) at IU Health to help fill this critical gap through a new support program, Technology Enhancement Awards (TEA), for early stage technologies. The technology may already reside in a start-up company or a clear plan exists to place it into a start-up. The New Program will partner with the highly successful SPARK program at Stanford University.
Request for Proposals: Proposals are requested from Indiana University School of Medicine researchers and founders of start-up companies for funds to advance early stage technologies to commercialization. The technologies may include highly promising therapeutics (small molecule or biologics), diagnostics or biomedical devices. The funds will be used in support of closing the technical data gaps for commercialization.
Funding: The project will receive funding up to $50,000 for a period of 12 months through a milestone based project management mechanism. In addition, advice and mentorship from experts in drug, diagnostics and business development will be available.
Eligibility: Applicants must be researchers, including post docs, within the Indiana University School of Medicine. Post-doc applicants will require letter of support from the primary faculty mentor or the Department Chair.
Contact Name: Padma Portonovo
Contact Email: email@example.com
- Review the complete guidelines for the RFA.
- Click on the link below for completing the applications procedure: http://www.in-bioinnovation.org/grants-funding/